Cargando…
Epigenetic Drivers in Pediatric Medulloblastoma
Epigenetics is the process by which gene expression is regulated by events other than alterations of the genome. This includes DNA methylation, histone modifications, chromatin remodeling, microRNAs, and long non-coding RNAs. Methylation of DNA, chromatin remodeling, and histone modifications regula...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807456/ https://www.ncbi.nlm.nih.gov/pubmed/29178021 http://dx.doi.org/10.1007/s12311-017-0899-9 |
_version_ | 1783299270424657920 |
---|---|
author | Roussel, Martine F. Stripay, Jennifer L. |
author_facet | Roussel, Martine F. Stripay, Jennifer L. |
author_sort | Roussel, Martine F. |
collection | PubMed |
description | Epigenetics is the process by which gene expression is regulated by events other than alterations of the genome. This includes DNA methylation, histone modifications, chromatin remodeling, microRNAs, and long non-coding RNAs. Methylation of DNA, chromatin remodeling, and histone modifications regulate the chromatin and access of transcription factors to DNA and in turn gene transcription. Alteration of chromatin is now recognized to be deregulated in many cancers. Medulloblastoma is an embryonal tumor of the cerebellum and the most common malignant brain tumor in children, that occurs only rarely in adults. Medulloblastoma is characterized by four major molecularly and histopathologically distinct groups, wingless (WNT), sonic hedgehog (SHH), group 3 (G3), and group 4 (G4), that, except for WNT, are each now subdivided in several subgroups. Gene expression array, next-generation sequencing, and methylation profiling of several hundred primary tumors by several consortia and independent groups revealed that medulloblastomas harbor a paucity of mutations most of which occur in epigenetic regulators, genetic alterations in oncogenes and tumor suppressors, in addition to copy number alterations and chromosome gains and losses. Remarkably, some tumors have no reported mutations, suggesting that some genes required for oncogenesis might be regulated by epigenetic mechanisms which are still to be uncovered and validated. This review will highlight several epigenetic regulators focusing mainly on histone modifiers identified in medulloblastoma. |
format | Online Article Text |
id | pubmed-5807456 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-58074562018-02-13 Epigenetic Drivers in Pediatric Medulloblastoma Roussel, Martine F. Stripay, Jennifer L. Cerebellum Review Epigenetics is the process by which gene expression is regulated by events other than alterations of the genome. This includes DNA methylation, histone modifications, chromatin remodeling, microRNAs, and long non-coding RNAs. Methylation of DNA, chromatin remodeling, and histone modifications regulate the chromatin and access of transcription factors to DNA and in turn gene transcription. Alteration of chromatin is now recognized to be deregulated in many cancers. Medulloblastoma is an embryonal tumor of the cerebellum and the most common malignant brain tumor in children, that occurs only rarely in adults. Medulloblastoma is characterized by four major molecularly and histopathologically distinct groups, wingless (WNT), sonic hedgehog (SHH), group 3 (G3), and group 4 (G4), that, except for WNT, are each now subdivided in several subgroups. Gene expression array, next-generation sequencing, and methylation profiling of several hundred primary tumors by several consortia and independent groups revealed that medulloblastomas harbor a paucity of mutations most of which occur in epigenetic regulators, genetic alterations in oncogenes and tumor suppressors, in addition to copy number alterations and chromosome gains and losses. Remarkably, some tumors have no reported mutations, suggesting that some genes required for oncogenesis might be regulated by epigenetic mechanisms which are still to be uncovered and validated. This review will highlight several epigenetic regulators focusing mainly on histone modifiers identified in medulloblastoma. Springer US 2017-11-25 2018 /pmc/articles/PMC5807456/ /pubmed/29178021 http://dx.doi.org/10.1007/s12311-017-0899-9 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Roussel, Martine F. Stripay, Jennifer L. Epigenetic Drivers in Pediatric Medulloblastoma |
title | Epigenetic Drivers in Pediatric Medulloblastoma |
title_full | Epigenetic Drivers in Pediatric Medulloblastoma |
title_fullStr | Epigenetic Drivers in Pediatric Medulloblastoma |
title_full_unstemmed | Epigenetic Drivers in Pediatric Medulloblastoma |
title_short | Epigenetic Drivers in Pediatric Medulloblastoma |
title_sort | epigenetic drivers in pediatric medulloblastoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807456/ https://www.ncbi.nlm.nih.gov/pubmed/29178021 http://dx.doi.org/10.1007/s12311-017-0899-9 |
work_keys_str_mv | AT rousselmartinef epigeneticdriversinpediatricmedulloblastoma AT stripayjenniferl epigeneticdriversinpediatricmedulloblastoma |